Pitavastatin (Livalo)
A prescription cholesterol-lowering statin with fewer drug interactions and a neutral to favourable effect on blood sugar.

The links above are labelled third-party affiliate links. MolekulaX does not sell and does not verify product quality.

DETAILED OVERVIEW
What is Pitavastatin (Livalo)?
Pitavastatin (Livalo) is a prescription cholesterol-lowering medicine, a statin. It is approved for high cholesterol and mixed disorders of blood fats in Japan, the United States and Europe. In the liver it slows cholesterol production, so the liver pulls more LDL (the so-called bad cholesterol) out of the blood.
It differs from other statins in two ways. It largely bypasses the liver's main drug-processing enzymes (cytochrome P450), so it has substantially fewer drug interactions. Its effect on blood sugar is neutral to favourable, while statins as a class can slightly raise the risk of diabetes. It must not be taken with ciclosporin, because its level can rise many times over, and with it the risk of muscle damage. It is also prohibited in pregnancy and breastfeeding. Rarely, severe muscle damage can occur, signalled by dark urine and marked muscle pain.
Mechanism
HMG-CoA reductase inhibition: reduced hepatic cholesterol synthesis, upregulated LDL receptors.
What is different
Barely metabolised by cytochrome P450, hence fewer drug interactions.
Blood glucose
Neutral to favourable effect, in contrast to the class's mild diabetes signal.
Outcome data
In stable coronary artery disease, more intensive treatment gave better outcomes
Bioavailability
~51%, relatively high for a statin.
No anecdote collected yet.
Data console
Lab data
Adams SP, Alaeiilkhchi N, Wright JM . Pitavastatin for lowering lipids.. The Cochrane database of systematic reviews.
Hoy SM . Pitavastatin: A Review in Hypercholesterolemia.. American journal of cardiovascular drugs : drugs, devices, and other interventions.
Taguchi I, Iimuro S, Iwata H . High-Dose Versus Low-Dose Pitavastatin in Japanese Patients With Stable Coronary Artery Disease (REAL-CAD): A Randomized Superiority Trial.. Circulation.
Barrios V, Escobar C . Clinical benefits of pitavastatin: focus on patients with diabetes or at risk of developing diabetes.. Future cardiology.
Safety
Side effects, stop signs, contraindications
Side effects · 3
- Muscle pain and weakness: the characteristic class effect of statins. Rhabdomyolysis is rare but possible, signalled by dark urine and marked muscle pain, and requires immediate medical attention.
- Rising liver enzymes: usually mild and transient; worth checking at the start of treatment and on dose increase.
- Gastrointestinal complaints and headache: common, mild effects that usually do not require stopping treatment.
Contraindications · 4
- Concurrent ciclosporin: an absolute contraindication, as transporter inhibition raises pitavastatin levels many-fold along with the risk of muscle injury.
- Active liver disease or persistent unexplained transaminase elevation.
- Pregnancy and breastfeeding: contraindicated.
- In severe renal impairment caution and dose adjustment are needed; the risk of rhabdomyolysis is higher.
Related Pharmaceuticals
Same therapeutic category
Studies
Related research and clinical findings
Pitavastatin for lowering lipids.
Adams SP, Alaeiilkhchi N, Wright JM
Pitavastatin: A Review in Hypercholesterolemia.
Hoy SM
High-Dose Versus Low-Dose Pitavastatin in Japanese Patients With Stable Coronary Artery Disease (REAL-CAD): A Randomized Superiority Trial.
Taguchi I, Iimuro S, Iwata H
Clinical benefits of pitavastatin: focus on patients with diabetes or at risk of developing diabetes.
Barrios V, Escobar C
Telegram
Have a question about Pitavastatin (Livalo)?
Educational drug info from official sources (PubMed, FDA, EMA). Does NOT replace medical consultation or the SmPC. Talk to your doctor!
Personalized consultation
Want a detailed conversation tailored to your data?
Fill out the prep intake form (your goals, training and health data), and the advisor prepares from it to give genuinely personalized guidance.
Fill out the form~5–7 min · prep questionnaire · confidential · GDPR-compliant
The information here is for educational and scientific purposes only. Medication use requires medical consultation and a prescription. The indications, dose ranges, and side effects listed here do NOT replace the official Summary of Product Characteristics (SmPC) or consultation with a physician. Do not start or stop any medication on your own. In an emergency, call your local emergency number.